The Microbiome in PDAC—Vantage Point for Future Therapies?

The Microbiome in PDAC—Vantage Point for Future Therapies?

Microorganisms have been increasingly implicated in the pathogenesis of malignant diseases, potentially affecting different hallmarks of cancer. Despite the fact that we have recently gained tremendous insight into the existence and interaction of the microbiome with neoplastic cells, we are only be...

Full description

Bibliographic Details
Main Authors: Nina Pfisterer, Catharina Lingens, Cathleen Heuer, Linh Dang, Albrecht Neesse, Christoph Ammer-Herrmenau
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
microbiome
pancreatic ductal adenocarcinoma
contamination
biomarker
Online Access:https://www.mdpi.com/2072-6694/14/23/5974

Similar Items

Similar Items